Catalyst Repository | Virios Therapeutics Inc. Common Stock

Virios Therapeutics Inc. Common Stock

(NASDAQ:VIRI)

Description

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was incorporated in 2012 and is headquartered in Alpharetta, Georgia.

VIRI Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$2.1400
Previous Close Volume
745920


Latest News